Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy.
- A. Panossian, G. Wikman, J. Sarris
- BiologyPhytomedicine
- 1 June 2010
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness.
- J. Firth, N. Siddiqi, B. Stubbs
- MedicineLancet psychiatry
- 1 August 2019
Can smartphone mental health interventions reduce symptoms of anxiety? A meta-analysis of randomized controlled trials.
- J. Firth, J. Torous, J. Nicholas, R. Carney, S. Rosenbaum, J. Sarris
- Psychology, MedicineJournal of Affective Disorders
- 15 August 2017
The efficacy of smartphone‐based mental health interventions for depressive symptoms: a meta‐analysis of randomized controlled trials
Results indicate that smartphone devices are a promising self‐management tool for depression, and future research should aim to distil which aspects of these technologies produce beneficial effects, and for which populations.
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
- J. Sarris, A. Panossian, I. Schweitzer, C. Stough, A. Scholey
- Psychology, BiologyEuropean Neuropsychopharmacology
- 1 December 2011
A Randomized, Controlled Trial of Meditation for Work Stress, Anxiety and Depressed Mood in Full-Time Workers
- R. Manocha, D. Black, J. Sarris, C. Stough
- PsychologyEvidence-Based Complementary and Alternative…
- 7 June 2011
The findings suggest that “thought reduction” or “mental silence” may have specific effects relevant to work stress and hence occupational health.
Kava: A Comprehensive Review of Efficacy, Safety, and Psychopharmacology
- J. Sarris, E. Laporte, I. Schweitzer
- Psychology, MedicineAustralian and New Zealand journal of psychiatry…
- 1 January 2011
The current weight of evidence supports the use of kava in treatment of anxiety with a significant result occurring in four out of six studies reviewed, and more studies are required to assess comparative efficacy and safety versus established pharmaceutical comparators.
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
- J. Sarris, J. Sinclair, D. Karamacoska, Maggie Davidson, J. Firth
- Medicine, PsychologyBMC Psychiatry
- 16 January 2020
There is currently encouraging, albeit embryonic, evidence for medicinal cannabis in the treatment of a range of psychiatric disorders, however, clinicians need to be mindful of arange of prescriptive and occupational safety considerations, especially if initiating higher dose THC formulas.
The Effects of Dietary Improvement on Symptoms of Depression and Anxiety: A Meta-Analysis of Randomized Controlled Trials
Dietary interventions hold promise as a novel intervention for reducing symptoms of depression across the population, and studies with female samples observed significantly greater benefits from dietary interventions, for symptoms of both depression and anxiety.
...
...